دورية أكاديمية

Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures

التفاصيل البيبلوغرافية
العنوان: Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures
المؤلفون: S. Jarius, J. Haas, F. Paul, B. Wildemann
المصدر: Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
بيانات النشر: BMC, 2019.
سنة النشر: 2019
المجموعة: LCC:Neurology. Diseases of the nervous system
مصطلحات موضوعية: Schilder’s disease, Myelinoclastic diffuse sclerosis, Encephalitis periaxialis Schilder, Multiple sclerosis, Tumefactive, Demyelination, Neurology. Diseases of the nervous system, RC346-429
الوصف: Abstract Background Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear whether MDS is a variant of multiple sclerosis (MS) or a disease entity in its own right. Objective To compare the cerebrospinal fluid (CSF) features of MDS with those of MS. Methods Retrospective analysis of the CSF profile of all patients with MDS reported in the medical literature between 1960 and 2018. Results The most striking finding was a substantial lack of oligoclonal bands (OCBs) in MDS, which were absent in at least 77% (30/39) of all lumbar punctures (LP) in the total cohort and in 86% in the subgroup of patients with normal very long-chain fatty acid serum ratios (VLCFA). Almost all cases published in the past 15 years were negative for OCBs. These findings are in contrast to MS, in which OCBs are present in up to 98% of cases (p 100 mg/dL in 13/22; up to 220 mg/dL). EBV serum antibodies, which are present in virtually all patients with MS, and the so-called MRZ (measles/rubella/zoster) reaction, a highly specific marker of MS, were absent in all of the few patients tested. In addition, we discuss further differences between MS and MDS, taking into account also Schilder’s original comprehensive case description from 1912. Conclusion In the majority of patients diagnosed with MDS, CSF features differ significantly from those typically found in MS and are more similar to those previously reported in patients with myelin oligodendrocyte glycoprotein-immunoglobulin G (IgG)-positive encephalomyelitis, aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders or Baló’s concentric sclerosis. Our data suggest that MDS and MS are immunopathologically distinct entities in the majority of cases.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1742-2094
Relation: http://link.springer.com/article/10.1186/s12974-019-1425-4; https://doaj.org/toc/1742-2094
DOI: 10.1186/s12974-019-1425-4
URL الوصول: https://doaj.org/article/4256c4e3460d4ce7951bc671579092ee
رقم الأكسشن: edsdoj.4256c4e3460d4ce7951bc671579092ee
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:17422094
DOI:10.1186/s12974-019-1425-4